Collaborative Research Development Grant
Funding Amount
Up to US $900,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Educational and not-for-profit organizations from anywhere in the world are welcome to apply for OCRA grants.
Other requirements
- The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility.
- At least one key investigator must be a physician with expertise on ovarian cancer.
- International collaborations are welcome.
- The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics.
Not eligible / not funded
- Not eligible: Principal Investigator should not currently be in a training program.
- Not eligible: Profit entities
- Not eligible: Tuition and fees are not an allowable cost on OCRA grants.
Overview
The Collaborative Research Development Grant from the Ovarian Cancer Research Fund Alliance aims to support innovative research projects focused on ovarian and related gynecologic cancers. Funding of up to $300,000 per year for three years is available for interdisciplinary teams of investigators. The grant encourages creative and original applications that promise advancements in cancer detection, prevention, and treatment. This initiative fosters collaboration among institutions and welcomes international applicants to enhance research efforts in this critical area.
The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.
Funding
Support of up to $300,000USD annually for three years ($900,000USD total) will be granted to the institution(s) in which the recipients will conduct the research.
Eligibility
The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility. At least one key investigator must be a physician with expertise on ovarian cancer.International collaborations are welcome.The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics. Submissions that focus on health services research, quality of life, and epidemiology are also encouraged. Proposed projects should focus on ovarian cancers and/or related gynecologic cancers.The primary review criteria will be the likelihood that the investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding.International applicants are welcome to apply.Each applicant may submit only one LOI per grant cycle.Additionally, grant recipients can only have one OCRA grant active at a time, if the grant recipient already has an active OCRA grant, the current grant must end before the CRDG may begin.Educational and not-for-profit organizations from anywhere in the world are welcome to apply for OCRA grants.
Ineligibility
Principal Investigator should not currently be in a training program.At this time, OCRA does not fund for-profit entities.Tuition and fees are not an allowable cost on OCRA grants.
What The Ovarian Cancer Research Fund Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 14
- Total given
- $5.67M
- Median grant
- $325K
- Range
- $75K–$900K
- By dollars: Virginia 16%, Minnesota 16%, Massachusetts 16%. Top recipient cities: Houston, TX; Ashburn, VA; Bagley, MN.
- 0% of grants with a stated purpose were for general or operating support.
- 64% of recipients were new grantees, not repeat recipients.
Example grants
The George Washington University · Ashburn, VA
Research
$900K
University of Minnesota · Bagley, MN
Research
$900K
Children's Hospital Corporation (DBA Boston Children's Hospital) · Boston, MA
Research
$899K
Northwestern University · Evanston, IL
Research
$550K
Washington University in St Louis · Saint Louis, MO
Research
$550K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Nonprofits
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
DoW Military Burn, Technology/Therapeutic Development Award
Defense Health Agency Contracting Activity - DHACA
Amount
$5,000,000 total
Deadline
October 21, 2026
DoW Military Burn, Patient-Centered Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$3,400,000 total
Deadline
October 21, 2026
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,650,000 total
Deadline
October 22, 2026
DoW Arthritis Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$7,150,000 total
Deadline
October 22, 2026
DoW Arthritis Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
October 22, 2026
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Ready to apply for Collaborative Research Development Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Collaborative Research Development Grant. Now let's win it.